Correlation Between Enfusion and Workiva
Can any of the company-specific risk be diversified away by investing in both Enfusion and Workiva at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enfusion and Workiva into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enfusion and Workiva, you can compare the effects of market volatilities on Enfusion and Workiva and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enfusion with a short position of Workiva. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enfusion and Workiva.
Diversification Opportunities for Enfusion and Workiva
Very poor diversification
The 3 months correlation between Enfusion and Workiva is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Enfusion and Workiva in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Workiva and Enfusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enfusion are associated (or correlated) with Workiva. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Workiva has no effect on the direction of Enfusion i.e., Enfusion and Workiva go up and down completely randomly.
Pair Corralation between Enfusion and Workiva
Given the investment horizon of 90 days Enfusion is expected to generate 1.13 times less return on investment than Workiva. In addition to that, Enfusion is 1.04 times more volatile than Workiva. It trades about 0.19 of its total potential returns per unit of risk. Workiva is currently generating about 0.22 per unit of volatility. If you would invest 7,481 in Workiva on September 3, 2024 and sell it today you would earn a total of 2,244 from holding Workiva or generate 30.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Enfusion vs. Workiva
Performance |
Timeline |
Enfusion |
Workiva |
Enfusion and Workiva Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enfusion and Workiva
The main advantage of trading using opposite Enfusion and Workiva positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enfusion position performs unexpectedly, Workiva can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Workiva will offset losses from the drop in Workiva's long position.Enfusion vs. ON24 Inc | Enfusion vs. Paycor HCM | Enfusion vs. E2open Parent Holdings | Enfusion vs. Braze Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |